Uppsala Reports editor
The WHO Programme for International Drug Monitoring continues to grow. Since we last reported on programme membership (Issue 81, October 2019), three countries have become full members: Luxembourg (January 2020), Saint Vincent and the Grenadines (March), and Nicaragua (April). In addition, Belize and Dominican Republic joined as associate members (January and March, respectively).
The programme now stands at 139 full and 32 associate members.